GnRH Agonist May Protect Ovaries During Early Breast Cancer Treatment
Treatment with the gonadotropin-releasing hormone (GnRH) agonist goserelin can reduce the risk of chemotherapy-induced premature ovarian insufficiency (POI) in women with early breast cancer.
Blended Cognitive Behavior Therapy May Reduce Fear of Cancer Recurrence
Blended cognitive behavior therapy can help reduce the severity of fear of cancer recurrence in survivors, according to a new randomized study.
Might Chlorhexidine Wipes Reduce CLABSI Risk for Cancer Patients?
Chlorhexidine wipe bathing might help reduce the risk of deadly central line-associated bloodstream infections (CLABSIs) among cancer inpatients, but barriers can complicate implementation efforts.
Role of Nurse Practitioners in Managing Esophageal Cancer, Complications
Nurse practitioners play a central role in helping patients with esophageal cancer understand and manage their disease and treatment complications.
Dexrazoxane Adds Cardioprotective Effect in HER2-Positive Breast Cancer
Administration of dexrazoxane along with adjuvant chemotherapy was cardioprotective in patients with HER2-positive breast cancer treated with chemotherapy followed by 1 year of trastuzumab maintenance therapy.
Cancer-Related End-Stage Renal Disease Incidence Increasing
From 1983 to 2007, the incidence of renal-malignancy end-stage renal disease has greatly increased, according to the results of a study.
Score Based on Patient Factors Can Predict Nausea and Vomiting
A risk scoring algorithm based on several risk factors was able to accurately predict chemotherapy-induced nausea and vomiting.
Managing Thrombosis in Cancer Patients
This video reviews recommendations for the prevention and management of thrombosis in patients with cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.